S. Thompson

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.

D. Neal, D. Lane, M. Robinson, 1992, The Journal of urology.

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial

L. Holmberg, J. Oxley, J. Sterne, 2016, Trials.

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia.

D. Neal, M. Robinson, K. Mellon, 1992, British journal of urology.

Effect of 13-cis-retinoic acid and α-interferon on transforming growth factor in patients with rising prostate-specific antigen

R. DiPaola, M. Anscher, Z. Rasheed, 1997 .